Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014078 · ClinicalTrials.gov registry record · Phase 4
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
A Phase 4 study, sponsored by Merck Sharp & Dohme.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT01014078 is a Phase 4 study that has completed, run by Merck Sharp & Dohme. The registered enrollment target is 112 participants.
The verdict
NCT01014078, a Phase 4 study, has completed, sponsored by Merck Sharp & Dohme.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% in dry eye subjects over a four week treatment period, using placebo as a comparison.
Interventions
- DRUG Placebo
- DRUG Azithromycin Ophthalmic Solution, 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014078
The ClinicalTrials.gov registry entry for NCT01014078 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01014078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014078 about?
NCT01014078 is a clinical study titled "A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease". The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% in dry eye subjects over a four week treatment period, using placebo as a comparison.
What is the current status of trial NCT01014078?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2009-10. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01014078?
The interventions under investigation include: Placebo (DRUG), Azithromycin Ophthalmic Solution, 1% (DRUG).
Who is sponsoring clinical trial NCT01014078?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.